Evidence map›Paper›PMID 41855468›Full record

ArticleJMIR medical informatics2026

Machine Learning-Based Risk Prediction for Coronary Heart Disease Complicated by Hyperhomocysteinemia: Retrospective Study.

Ming-Yuan Du, Meng-Ke Lyu, Hai-Long Liu, Yi-Zhuo Li, Hai-Feng Yan, Xiao-Hui Li

Abstract read
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ming-Yuan DuHeart Center, The First Affiliated Hospital of Henan University of Chinese Medicine, National Regional (TCM) Cardiovascular Diagnosis and Treatment Center, Zhengzhou, China.ORCID 0009-0009-0965-619X
Meng-Ke LyuThe First Affiliated Hospital of Henan University of Traditional Chinese Medicine, No. 19 Renmin Road, Jinshui District, Henan Province, Zhengzhou, 450000, China, 86 15649856289.ORCID 0009-0002-2013-4201
Hai-Long LiuHeart Center, The First Affiliated Hospital of Henan University of Chinese Medicine, National Regional (TCM) Cardiovascular Diagnosis and Treatment Center, Zhengzhou, China.ORCID 0009-0001-3917-6674
Yi-Zhuo LiHeart Center, The First Affiliated Hospital of Henan University of Chinese Medicine, National Regional (TCM) Cardiovascular Diagnosis and Treatment Center, Zhengzhou, China.ORCID 0009-0002-4583-8301
Hai-Feng YanHeart Center, The First Affiliated Hospital of Henan University of Chinese Medicine, National Regional (TCM) Cardiovascular Diagnosis and Treatment Center, Zhengzhou, China.ORCID 0000-0003-1725-7825
Xiao-Hui LiHeart Center, The First Affiliated Hospital of Henan University of Chinese Medicine, National Regional (TCM) Cardiovascular Diagnosis and Treatment Center, Zhengzhou, China.ORCID 0000-0002-0258-4041

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for coronary heart disease (CHD), yet accurately predicting CHD risk in patients with HHcy remains a challenge. This study aimed to develop and validate multiple machine learning models for predicting CHD risk in patients with HHcy and elucidate key predictors using Shapley Additive Explanation (SHAP) algorithms. Objective: This study aims to develop and validate machine learning models for predicting the risk of coronary heart disease in individuals with normal homocysteine levels, aiming to improve early risk stratification and clinical decision-making. Methods: This single-center retrospective study collected data from patients who were diagnosed with HHcy through electronic medical records, which were randomly divided into training (n=364, 70%), validation (n=78, 15%), and test (n=78, 15%) sets. Seven machine learning models were constructed, including logistic regression, k-nearest neighbor, decision tree, random forest, extreme gradient boost, light gradient boosting machine (LightGBM), and stacking. Six core variables (age, weight, hypertension, continuous drinking history, activated partial thromboplastin time, and carotid plaque) were utilized as inputs, with performance evaluation metrics encompassing area under the receiver operating characteristic curve, accuracy, F1-score, calibration curve, Brier score, and decision curve analysis. Additionally, SHAP interpretation was conducted on the optimal LightGBM model. Results: The LightGBM model exhibited superior performance in the test set (area under the receiver operating characteristic curve=0.807, F1-score=0.606), demonstrated good calibration (Brier score=0.2415), and yielded high clinical net benefit. SHAP analysis revealed age and activated partial thromboplastin time as the most influential predictors, followed by hypertension, weight, carotid plaque, and continuous drinking history. The correlation heat map illustrated low collinearity among variables, ensuring model stability. Conclusions: The LightGBM model demonstrated high accuracy and interpretability in forecasting CHD risk among patients with HHcy. The integration of machine learning and interpretable artificial intelligence methods holds promise for delivering personalized early risk assessment and intervention strategies in clinical settings.

Indexed as

Coronary DiseaseHyperhomocysteinemiaMachine LearningAgedBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansLogistic ModelsMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsRandom ForestRetrospective StudiesRisk Assessmentcoronary heart diseasehyperhomocysteinemiamachine learningpredictive modelretrospective study

Identifiers

PMID41855468
PMCPMC13002003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.